Giacobello Scott M. (CIK 1754154) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-18). Recent activity: Buy WHWK (38,265 shares), Sell WHWK (77,000 shares), Sell WHWK (141,600 shares), Buy WHWK (473,902 shares), Buy WHWK (6,750 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF FINANCIAL OFFICER | Buy | 38,265 | $149,999 |
| 2026-04-17 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF FINANCIAL OFFICER | Sell | 77,000 | $297,220 |
| 2026-04-17 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF FINANCIAL OFFICER | Sell | 141,600 | $584,808 |
| 2026-04-03 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF FINANCIAL OFFICER | Buy | 473,902 | $0 |
| 2026-03-10 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF FINANCIAL OFFICER | Buy | 6,750 | $0 |
| 2026-03-10 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF FINANCIAL OFFICER | Sell | 2,594 | $8,586 |
| 2025-03-03 | Aadi Bioscience, Inc. (AADI) | CHIEF FINANCIAL OFFICER | Buy | 6,750 | $0 |
| 2025-03-03 | Aadi Bioscience, Inc. (AADI) | CHIEF FINANCIAL OFFICER | Sell | 2,806 | $6,594 |
Source: SEC Form 4 filings · as of 2026-05-18